Key points from article :
Dimension Inx, a Chicago-based bio-fabrication firm, has successfully used its FDA-approved 3D printed bone graft, CMFlex, in two surgical procedures.
CMFlex's unique architecture, encompassing macro, micro, and nano-level features, promotes bone regeneration, making it ideal for oral and maxillofacial surgeries.
Surgeons can customise CMFlex's size to fit each patient's needs, and its fluid-absorbing properties aid in bleeding control and bone remodelling.
Dr. Derek Steinbacher and Dr. Brian Farrell performed the first two surgeries, highlighting CMFlex's ease of handling and contouring.
CMFlex represents a breakthrough in medical 3D printing, demonstrating the potential of combining novel biomaterial design and 3D printing technologies.
With a broader release expected in 2024, CMFlex is poised to revolutionise bone grafting procedures and enhance patient outcomes.